These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 391624)

  • 21. Demonstration of the efficacy of ginkgo biloba special extract EGb 761 on intermittent claudication--a placebo-controlled, double-blind multicenter trial.
    Peters H; Kieser M; Hölscher U
    Vasa; 1998 May; 27(2):106-10. PubMed ID: 9612115
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Placebo-controlled, double-blind study of the effect of verapamil in intermittent claudication.
    Kimose HH; Bagger JP; Aagaard MT; Paulsen PK
    Angiology; 1990 Aug; 41(8):595-8. PubMed ID: 2202231
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Flunarizine in the prevention of classical migraine: a placebo-controlled evaluation.
    Mendenopoulos G; Manafi T; Logothetis I; Bostantjopoulou S
    Cephalalgia; 1985 Mar; 5(1):31-7. PubMed ID: 3886152
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A long-term study of policosanol in the treatment of intermittent claudication.
    Castaño G; Más Ferreiro R; Fernández L; Gámez R; Illnait J; Fernández C
    Angiology; 2001 Feb; 52(2):115-25. PubMed ID: 11228084
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The effectiveness of isoxsuprine in patients with intermittent claudication.
    Skotnicki SH; van Gaal G; Wijn PF
    Angiology; 1984 Nov; 35(11):685-93. PubMed ID: 6388424
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Failure of pentoxifylline or cilostazol to improve blood and plasma viscosity, fibrinogen, and erythrocyte deformability in claudication.
    Dawson DL; Zheng Q; Worthy SA; Charles B; Bradley DV
    Angiology; 2002; 53(5):509-20. PubMed ID: 12365857
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Management of intermittent claudication with pentoxifylline: meta-analysis of randomized controlled trials.
    Hood SC; Moher D; Barber GG
    CMAJ; 1996 Oct; 155(8):1053-9. PubMed ID: 8873633
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Oxatomide effects in follicular conjunctivitis of presumed allergic cause. A double-blind evaluation.
    Blockeel J; Leuridan O
    Ophthalmologica; 1980; 181(3-4):133-8. PubMed ID: 7015215
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The effects of sublingual glyceryl trinitrate on walking distance in patients with intermittent claudication. A randomised, doubled-blind, placebo-controlled, cross-over study.
    Heer R; Walker S; MacSweeney S
    Curr Med Res Opin; 2001; 17(2):113-5. PubMed ID: 11759179
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Does pentoxifylline prolong the walking distance in exercised claudicants? A placebo-controlled double-blind trial.
    Ernst E; Kollár L; Resch KL
    Angiology; 1992 Feb; 43(2):121-5. PubMed ID: 1536472
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A pilot study of ranolazine in patients with intermittent claudication.
    Ma A; Garland WT; Smith WB; Skettino S; Navarro MT; Chan AQ; Anderson BE; Cooke JP
    Int Angiol; 2006 Dec; 25(4):361-9. PubMed ID: 17164742
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Brain hypoxia in migraine: pathophysiologic and therapeutic implications.
    Amery WK
    J Cereb Blood Flow Metab; 1982; 2 Suppl 1():S62-5. PubMed ID: 7045147
    [No Abstract]   [Full Text] [Related]  

  • 33. Impact of a 4-week treatment with prostaglandin E1 on health-related quality of life of patients with intermittent claudication.
    Mangiafico RA; Messina R; Attinà T; Dell'Arte S; Giuliano L; Malatino LS
    Angiology; 2000 Jun; 51(6):441-9. PubMed ID: 10870853
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Therapy of chronic consequences of brain ischemia. Comparison between two drugs acting on brain circulation and metabolism.
    Passeri M
    Eur Neurol; 1978; 17 Suppl 1():150-8. PubMed ID: 381005
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Treatment of cerebrovascular insufficiency. A double blind trial of Cetal retard against cinnarizine (author's transl)].
    Bartels H
    MMW Munch Med Wochenschr; 1977 Oct; 119(43):1407-10. PubMed ID: 412079
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Heparan sulfate in the treatment of intermittent claudication: results of a randomized, double-blind, placebo-controlled multicenter trial.
    Messa GL; Gelso E
    Drugs Exp Clin Res; 2002; 28(1):37-48. PubMed ID: 12073766
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Comparison of the effectiveness of anginin and stugeron treatment of cerebral arteriosclerosis].
    Sobczyk W; Kruszewska J; Szymchel J
    Neurol Neurochir Pol; 1980; 14(2):183-9. PubMed ID: 6993976
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect of cilostazol in patients with intermittent claudication: a randomized, double-blind, placebo-controlled study.
    Strandness DE; Dalman RL; Panian S; Rendell MS; Comp PC; Zhang P; Forbes WP
    Vasc Endovascular Surg; 2002; 36(2):83-91. PubMed ID: 11951094
    [TBL] [Abstract][Full Text] [Related]  

  • 39. An evaluation of patients with severe intermittent claudication and the effect of treatment with naftidrofuryl.
    Moody AP; al-Khaffaf HS; Lehert P; Harris PL; Charlesworth D
    J Cardiovasc Pharmacol; 1994; 23 Suppl 3():S44-7. PubMed ID: 7517477
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A study on the efficacy and safety assessment of propionyl-L-carnitine tablets in treatment of intermittent claudication.
    Luo T; Li J; Li L; Yang B; Liu C; Zheng Q; Jin B; Chen Z; Li K; Zhang X; Zhang J
    Thromb Res; 2013 Oct; 132(4):427-32. PubMed ID: 23998557
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.